| Literature DB >> 26922301 |
Yunfei Wang1, Jiakai Hou1, Dandan He1, Ming Sun1, Peng Zhang1, Yonghao Yu2, Yiwen Chen3.
Abstract
Complex diseases, such as cancer, are often associated with aberrant gene expression at both the transcriptional and post-transcriptional level. Over the past several years, competing endogenous RNAs (ceRNAs) have emerged as an important class of post-transcriptional regulators that alter gene expression through a miRNA-mediated mechanism. Recent studies in both solid tumors and hematopoietic malignancies showed that ceRNAs have significant roles in cancer pathogenesis by altering the expression of key tumorigenic or tumor-suppressive genes. Characterizing the identity, function, and mechanism of the ceRNAs will not only further our fundamental understanding of RNA-mediated cancer pathogenesis, but may also shed light on the development of new RNA-based therapeutic strategies for treating cancer.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26922301 PMCID: PMC4805481 DOI: 10.1016/j.tig.2016.02.001
Source DB: PubMed Journal: Trends Genet ISSN: 0168-9525 Impact factor: 11.639